ArsenalBio
@ArsenalBio
Followers
2K
Following
14
Media
175
Statuses
197
We’re a programmable clinical-stage cell therapy company focused on the realization of solid tumor cell therapies. Our purpose is very clear: defeat cancer.
Joined October 2019
We’re gearing up for #SITC2025! We will share the latest research on our lead investigative cell therapy intended for mCRPC, CAR T cell therapy design, and our foundation model predicting targets for overcoming T cell exhaustion. Join us Nov 7–9: https://t.co/zdFBHCcMrz
0
0
1
We’re presenting at the @CAR_TCell Summit tomorrow on the development of our T cell therapy intended for metastatic prostate cancer and maintaining high potency in our development of cell therapy products. https://t.co/XdVBqwCjir
#CellTherapy #CancerResearch #ProstateCancer
0
0
2
We’re developing a CAR-T cell therapy as a potential treatment for metastatic prostate cancer, for which new and more effective treatments are urgently needed. Stay tuned as we advance this program toward the clinic. More: https://t.co/6CumKnINpg
#ProstateCancer #CancerResearch
0
3
16
Join ArsenalBio scientist Sophia Phillips on July 17 at the Process Development for Cell Therapies Summit for a case study on overcoming process development challenges in solid tumor-targeting cell therapies. https://t.co/tUOMG4aOMH
#CellTherapy #DrugDevelopment
0
1
2
On July 15 at the Process Development for Cell Therapies Summit, ArsenalBio scientist Max Lee will present during a workshop focused on implementing cutting-edge technology with phase-appropriate strategies. https://t.co/nMTSFNtVeK
#CellTherapy #Drug Development
0
0
0
Thanks to @BiotechTV and @bradloncar for sitting down with our CEO, @KDrazan , M.D., to hear about the latest on our CAR T cell therapies specifically designed to overcome the challenges presented by solid tumors. Full video available here: https://t.co/LKg4v71w9t
#CancerResearch
biotechtv.com
He describes the ArsenalBio's "CITE" platform, which allows it to make heterogenous cells by inserting modifications all in the same place. Plus, writing in logic gating, harnessing shRNA, and more....
𝐂𝐀𝐑-𝐓 𝐋𝐨𝐠𝐢𝐜-𝐆𝐚𝐭𝐢𝐧𝐠: @ArsenalBio CEO @KDrazan describes the idea of logic-gating, which might allow CAR-T therapies to work in solid tumors when targeting more than one antigen is needed. Full interview: https://t.co/bwoA7KXBaA
1
0
7
We’re honored to have @KDrazan, MD, Co-founder, CEO, and Chairman of the Board, recognized as a winner in the EY Entrepreneur Of The Year® 2025 Bay Area program. https://t.co/LeBqrfSaE6
#EOYUS #EOYBAYAREA
0
2
6
Heading to Fully Connected 2025? Hear from ArsenalBio’s Sofia Panagiotopoulou as she presents “A T-cell foundation model for AI-powered target discovery and precision medicine” on June 18. Learn more and view the full agenda: https://t.co/B7m0Yf7ID6
0
2
8
We’re proud to share that @KDrazan, MD, ArsenalBio’s Co-founder, CEO, and Chairman, has been recognized along with other inspiring business leaders as a finalist in the EY Entrepreneur Of The Year® 2025 Bay Area program. Learn more: https://t.co/L5puygD6FC
#EOYUS #EOYBAYAREA
0
1
4
Future scientists at work! Each year at ArsenalBio, we hold a Bring a Kid to Work Day, where young minds explore our labs and experience the wonders of #STEM. #BringYourKidToWorkDay #TakeYourChildToWorkDay
0
0
0
Our One Team value extends to our local community by helping our neighbors with a cleanup day. Happy Earth Day.
0
0
1
Next week at the @AACR Annual Meeting, we’ll share research on how our synthetic pathway activator (SPA) modules enhance the functional persistence of our CAR T cell therapies and prevent T cell exhaustion. https://t.co/ckEsDju66F
#AACR25 #CancerResearch
0
0
1
ArsenalBio CSO @nickhaining recently spoke with @DrugDiscovNews about our multi-pronged approach of equipping T cells to defeat solid tumors. Check out the article, "Armoring up CAR T cells to fight solid tumors" at https://t.co/FHEET4xIk2
#CancerResearch #CellTherapy
0
3
8
It’s a busy week for ArsenalBio as we present at three scientific conferences: Supply Chain & Logistics for Cell & Gene Therapies Summit, Cell Therapy Potency Assay Summit, and SITC Spring Scientific Cellular Therapy for Solid Tumors. Details on the image.
0
2
4
Happy #EmployeeAppreciationDay to our 270 employees! We're so grateful for you and your many contributions toward our collective mission of defeating cancer. #CancerResearch #Biotech
0
1
4
This Kidney Cancer Awareness Month, we reaffirm our commitment to developing cell therapies to defeat solid tumors such as kidney cancer. We are currently in a Phase 1/2 clinical study of AB-2100, our CAR T cell therapy for the potential treatment of clear-cell renal cell
0
0
1
In a Q&A on Sōzō, the SoftBank Investment Advisors blog, CEO @KDrazan describes how ArsenalBio's large language model (LLM) of the T cell works, the data that fuels the platform, and its powerful potential to accelerate drug development. Check it out: https://t.co/auAyzQfDeS
#AI
0
0
3
Proud moment: ArsenalBio is officially @GPTW_US Certified. This recognition highlights our inclusive, innovative culture where people thrive and make an impact. More here: https://t.co/u8iD5RoYw5
#GreatPlaceToWork #GPTWCertified
0
2
4
We are proud to celebrate International Day of Women and Girls in Science and the dedicated and talented women professionals at ArsenalBio. #WomeninScience #WomeninSTEM
0
1
6